Grants and Contracts Details
| Status | Finished |
|---|---|
| Effective start/end date | 10/1/07 → 8/31/11 |
A Phase 2/3 Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety & Efficacy of Golimumab Induction Therapy, Administered Subcutaneously, in Subjects with Moderately to Severely Active Ulcerative Colitis
- De Villiers, Willem (PI)